DK1289998T3 - Hidtil ukendt fremgangsmåde til fremstilling af vinyl-pyrrolidinon-cephalosporin-derivater - Google Patents

Hidtil ukendt fremgangsmåde til fremstilling af vinyl-pyrrolidinon-cephalosporin-derivater

Info

Publication number
DK1289998T3
DK1289998T3 DK01936374T DK01936374T DK1289998T3 DK 1289998 T3 DK1289998 T3 DK 1289998T3 DK 01936374 T DK01936374 T DK 01936374T DK 01936374 T DK01936374 T DK 01936374T DK 1289998 T3 DK1289998 T3 DK 1289998T3
Authority
DK
Denmark
Prior art keywords
preparation
new process
cephalosporin derivatives
vinyl pyrrolidinone
formula
Prior art date
Application number
DK01936374T
Other languages
English (en)
Inventor
Hans Hilpert
Paul Hebeisen
Roland Humm
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of DK1289998T3 publication Critical patent/DK1289998T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK01936374T 2000-05-24 2001-05-18 Hidtil ukendt fremgangsmåde til fremstilling af vinyl-pyrrolidinon-cephalosporin-derivater DK1289998T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00111164 2000-05-24
EP01936374A EP1289998B1 (en) 2000-05-24 2001-05-18 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives

Publications (1)

Publication Number Publication Date
DK1289998T3 true DK1289998T3 (da) 2005-08-08

Family

ID=8168825

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01936374T DK1289998T3 (da) 2000-05-24 2001-05-18 Hidtil ukendt fremgangsmåde til fremstilling af vinyl-pyrrolidinon-cephalosporin-derivater
DK04002120.6T DK1435357T3 (da) 2000-05-24 2001-05-18 Hidtil ukendt fremgangsmåde til fremstilling af vinyl-pyrrolidinon-cephalosporinderivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04002120.6T DK1435357T3 (da) 2000-05-24 2001-05-18 Hidtil ukendt fremgangsmåde til fremstilling af vinyl-pyrrolidinon-cephalosporinderivater

Country Status (15)

Country Link
US (1) US6504025B2 (da)
EP (2) EP1289998B1 (da)
JP (1) JP3994011B2 (da)
KR (1) KR100528305B1 (da)
CN (4) CN1301998C (da)
AT (2) ATE292135T1 (da)
AU (1) AU2001262299A1 (da)
CA (2) CA2408941C (da)
CY (1) CY1110298T1 (da)
DE (2) DE60109771T2 (da)
DK (2) DK1289998T3 (da)
ES (2) ES2238441T3 (da)
MX (1) MXPA02011530A (da)
PT (2) PT1289998E (da)
WO (1) WO2001090111A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE257136T1 (de) 2001-10-11 2004-01-15 Consortium Elektrochem Ind Verfahren zur oxidation von alkoholen unter katalyse von nitroxylverbindungen
MXPA05010083A (es) * 2003-03-27 2005-11-23 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
CN101835777A (zh) * 2007-10-25 2010-09-15 尔察祯有限公司 碳头孢烯β-内酰胺抗生素
AR071318A1 (es) * 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2010072672A1 (en) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag New crystal polymorphs of ceftobiprole
JP2012528102A (ja) * 2009-05-25 2012-11-12 サンド・アクチエンゲゼルシヤフト セフトビプロールメドカリルの製造方法
PT2569321E (pt) * 2010-05-10 2015-05-25 Basilea Pharmaceutica Int Ltd Processo de oxidação para a preparação de derivados 3-formil cefeme
CN103275104B (zh) * 2013-05-15 2015-05-20 苏州明锐医药科技有限公司 头孢托罗及头孢托罗酯的制备方法
CN105601648A (zh) * 2016-03-09 2016-05-25 上海宁瑞生化技术有限公司 一锅法制备头孢吡普的方法
CN117903122B (zh) * 2023-12-04 2026-07-31 杭州善礼生物医药科技有限公司 一种头孢比罗酯钠双环酯侧链的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT620225E (pt) * 1993-04-16 2003-03-31 Basilea Pharmaceutica Ag Derivados de cefalosporina
US5466811A (en) 1994-07-18 1995-11-14 Merck & Co., Inc. Dioxolenylmethyl carbamates pro moieties for amine drugs
US5631366A (en) * 1995-01-12 1997-05-20 Hoffmann-La Roche Inc. Process for making 3-formylcephem derivatives
KR100197788B1 (ko) 1995-06-30 1999-06-15 김충환 세펨 유도체의 제조방법
US5883247A (en) * 1996-06-10 1999-03-16 Hoffmann-La Roche Inc. Preparation of cephem and isooxacephem derivatives
TW415949B (en) 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents
BR9807913A (pt) * 1997-04-01 2000-02-22 Biochemie Gmbh 7-acilamino-3-(metilhidrazono)metil cefalosporinas substituìdas antibacterianas e intermediários
JP3872955B2 (ja) 1998-06-15 2007-01-24 バジリア ファルマスーチカ アーゲー 3−(2−オキソ−〔1,3′〕ビピロリジニル−3−イリデンメチル)−セフェムの誘導体

Also Published As

Publication number Publication date
EP1435357A2 (en) 2004-07-07
DE60109771D1 (de) 2005-05-04
ATE461203T1 (de) 2010-04-15
PT1289998E (pt) 2005-06-30
KR20030005386A (ko) 2003-01-17
ES2340273T3 (es) 2010-06-01
EP1435357B1 (en) 2010-03-17
PT1435357E (pt) 2010-04-20
ES2238441T3 (es) 2005-09-01
CA2408941C (en) 2009-01-27
US6504025B2 (en) 2003-01-07
CA2408941A1 (en) 2001-11-29
DE60141609D1 (de) 2010-04-29
CN1301998C (zh) 2007-02-28
CN1915997B (zh) 2010-06-16
CN1603327A (zh) 2005-04-06
EP1289998A1 (en) 2003-03-12
CN1916006A (zh) 2007-02-21
JP3994011B2 (ja) 2007-10-17
MXPA02011530A (es) 2003-04-25
HK1096101A1 (zh) 2007-05-25
CN1915997A (zh) 2007-02-21
WO2001090111A1 (en) 2001-11-29
US20020019381A1 (en) 2002-02-14
HK1074620A1 (en) 2005-11-18
EP1435357A3 (en) 2006-05-03
DK1435357T3 (da) 2010-05-03
KR100528305B1 (ko) 2005-11-15
CN1170831C (zh) 2004-10-13
CA2583727C (en) 2010-03-30
DE60109771T2 (de) 2006-02-16
CA2583727A1 (en) 2001-11-29
CN100567314C (zh) 2009-12-09
AU2001262299A1 (en) 2001-12-03
JP2003535059A (ja) 2003-11-25
EP1289998B1 (en) 2005-03-30
ATE292135T1 (de) 2005-04-15
HK1096091A1 (zh) 2007-05-25
CY1110298T1 (el) 2015-04-29
CN1430621A (zh) 2003-07-16

Similar Documents

Publication Publication Date Title
CY1110298T1 (el) Νεα μεθοδος για την παρασκευη παραγωγων βινυλ-πυρρολιδινο κεφαλοσπορινων
GT200200145A (es) Nuevos compuestos fungicidas
DK1322648T3 (da) 3-(heteroarylacetamido)-2-oxo-azetidin-1-sulfonsyrederivater som antibakterielle midler
NO20052787L (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
CY1114476T1 (el) Παραγωγο 7-(4-υποκατεστημενου 3-κυκλοπροπυλαμινομεθυλο-1-πυρρολιδινυλο) κινολονοκαρβοξυλικου οξεος
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
PL372885A1 (pl) Benzamidy i kompozycje benzamidów do stosowania jako środki grzybobójcze
TW200616541A (en) Benzoyl-substituted serineamides
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
TR200400630T4 (tr) Ketolit antibiyotikleri
MXPA05009688A (es) Derivados de naftiridina como agentes antibacterianos.
AU2002325394A1 (en) Heterocyclic carboxamides and their use as fungicides
EP1251134A4 (en) NEW CARBAPENEM DERIVATIVES OF THE QUATERNARY SALT TYPE
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
DK1334105T3 (da) Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat)
NO20012541L (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20010140L (no) Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse
PT1167376E (pt) Antibioticos macrolidos
DK1338596T3 (da) Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypen
NO20061355L (no) Fungicide blandinger for kontroll av rispatogener
NO20012540L (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
DE60326710D1 (de) Trizyklische antibakterielle makrolidderivate
DE60106390D1 (de) Neue carbapenem-derivate
MXPA06000024A (es) Mezclas fungicidas para combatir patogenos del arroz.
DK1614684T3 (da) Diaminderivat, produktionsproces og antioxidantlægemiddel